TNDM · Categories · Coverage
TNDM - Analyst coverage initiated
Tandem Diabetes Care Inc. (TNDM) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for TNDM
- Barclays initiated coverage on Tandem Diabetes Care with a new price targetBarclays initiated coverage of Tandem Diabetes Care with a rating of Equal Weight and set a new price target of $18.00
- William Blair initiated coverage on Tandem Diabetes CareWilliam Blair initiated coverage of Tandem Diabetes Care with a rating of Outperform
- Deutsche Bank initiated coverage on Tandem Diabetes Care with a new price targetDeutsche Bank initiated coverage of Tandem Diabetes Care with a rating of Hold and set a new price target of $15.50
- The Benchmark Company initiated coverage on Tandem Diabetes CareThe Benchmark Company initiated coverage of Tandem Diabetes Care with a rating of Hold
- Oppenheimer initiated coverage on Tandem Diabetes Care with a new price targetOppenheimer initiated coverage of Tandem Diabetes Care with a rating of Outperform and set a new price target of $22.00
- Truist initiated coverage on Tandem Diabetes Care with a new price targetTruist initiated coverage of Tandem Diabetes Care with a rating of Hold and set a new price target of $24.00
- Mizuho initiated coverage on Tandem Diabetes Care with a new price targetMizuho initiated coverage of Tandem Diabetes Care with a rating of Neutral and set a new price target of $20.00
- Bernstein initiated coverage on Tandem Diabetes Care with a new price targetBernstein initiated coverage of Tandem Diabetes Care with a rating of Outperform and set a new price target of $42.00
- Goldman initiated coverage on Tandem Diabetes Care with a new price targetGoldman initiated coverage of Tandem Diabetes Care with a rating of Neutral and set a new price target of $46.00
- RBC Capital Mkts initiated coverage on Tandem Diabetes Care with a new price targetRBC Capital Mkts initiated coverage of Tandem Diabetes Care with a rating of Outperform and set a new price target of $65.00
- Morgan Stanley initiated coverage on Tandem Diabetes Care with a new price targetMorgan Stanley initiated coverage of Tandem Diabetes Care with a rating of Equal-Weight and set a new price target of $45.00
- Canaccord Genuity initiated coverage on Tandem Diabetes Care with a new price targetCanaccord Genuity initiated coverage of Tandem Diabetes Care with a rating of Buy and set a new price target of $57.00
- Redburn Atlantic initiated coverage on Tandem Diabetes Care with a new price targetRedburn Atlantic initiated coverage of Tandem Diabetes Care with a rating of Buy and set a new price target of $60.00
- UBS initiated coverage on Tandem Diabetes Care with a new price targetUBS initiated coverage of Tandem Diabetes Care with a rating of Neutral and set a new price target of $45.00
- Wolfe Research initiated coverage on Tandem Diabetes CareWolfe Research initiated coverage of Tandem Diabetes Care with a rating of Peer Perform
- Barclays initiated coverage on Tandem Diabetes Care with a new price targetBarclays initiated coverage of Tandem Diabetes Care with a rating of Overweight and set a new price target of $75.00
- Jefferies initiated coverage on Tandem Diabetes Care with a new price targetJefferies initiated coverage of Tandem Diabetes Care with a rating of Buy and set a new price target of $75.00
- Barclays initiated coverage on Tandem Diabetes Care with a new price targetBarclays initiated coverage of Tandem Diabetes Care with a rating of Underweight and set a new price target of $90.00